Auto saved by Logseq

master
Borja Robert 10 months ago
parent c178932815
commit a9e0e98178

@ -11,4 +11,6 @@
The clinical trial will have two arms, randomized by school. One arm will receive a single dose of the fixed-dose coformulation tablet (alb 400mg/ivm 9mg for children between 5 and 14 years old, alb 400mg/ivm 18mg for 15-17s), while the other, acting as an active control group, will receive a single dose of albendazole 400mg.
If you want to review the full protocol, please visit the REALISE study's page at clinicaltrials.gov or PACTR.
#+END_VERSE
Loading…
Cancel
Save